Systematic Review of Binge Eating Rodent Models for Developing Novel or Repurposing Existing Pharmacotherapies

Bibliographic Details
Title: Systematic Review of Binge Eating Rodent Models for Developing Novel or Repurposing Existing Pharmacotherapies
Authors: Gregory Berger, Joshua D. Corris, Spencer E. Fields, Lihong Hao, Lori L. Scarpa, Nicholas T. Bello
Source: Biomolecules, Vol 13, Iss 5, p 742 (2023)
Publisher Information: MDPI AG, 2023.
Publication Year: 2023
Collection: LCC:Microbiology
Subject Terms: eating pathologies, binge, Vyvanse, fluoxetine, Prozac, rat, Microbiology, QR1-502
More Details: Recent advances in developing and screening candidate pharmacotherapies for psychiatric disorders have depended on rodent models. Eating disorders are a set of psychiatric disorders that have traditionally relied on behavioral therapies for effective long-term treatment. However, the clinical use of Lisdexamfatamine for binge eating disorder (BED) has furthered the notion of using pharmacotherapies for treating binge eating pathologies. While there are several binge eating rodent models, there is not a consensus on how to define pharmacological effectiveness within these models. Our purpose is to provide an overview of the potential pharmacotherapies or compounds tested in established rodent models of binge eating behavior. These findings will help provide guidance for determining pharmacological effectiveness for potential novel or repurposed pharmacotherapies.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2218-273X
Relation: https://www.mdpi.com/2218-273X/13/5/742; https://doaj.org/toc/2218-273X
DOI: 10.3390/biom13050742
Access URL: https://doaj.org/article/8ea7e29e88a6485cb92e974fce1d2045
Accession Number: edsdoj.8ea7e29e88a6485cb92e974fce1d2045
Database: Directory of Open Access Journals
More Details
ISSN:2218273X
DOI:10.3390/biom13050742
Published in:Biomolecules
Language:English